Title 43, Chapter 34, Section 125
(a) The composite board shall apply to contract with the National
Institute on Drug Abuse for receipt of marijuana pursuant to this
article and pursuant to regulations promulgated by the National
Institute on Drug Abuse, the Food and Drug Administration, and the
Federal Drug Enforcement Agency.
(b) The composite board shall cause marijuana approved for use in
the program to be transferred to a certified pharmacy, licensed by
the state, for distribution to the certified patient by a licensed
pharmacist upon a written order for research medication of the
certified physician, pursuant to this article. Any reasonable costs
incurred by the composite board in obtaining or testing marijuana
shall be charged to participating physicians who may seek
reimbursement from their research subjects utilizing the marijuana.